Our professionals

Imagen de la Dra. Marta Santisteban Eslava, especialista en Oncología Médica de la Clínica Universidad de Navarra. La Dra. Santisteban se dedica preferencialmente a la oncología de mama.

Dr. Marta Santisteban

Specialist in Medical Oncology.
Primary focus on breast oncology

Works at: Navarre headquarters
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 18

Professional career

MD degree (1995) and PhD in Medicine and Surgery (2005) from the University of Navarra. Specialist in Medical Oncology at Clínica Universidad de Navarra (2001).

She completed her training with a fellowship in Oncology Research and obtained the Certificate of Training in Molecular and Biological Techniques at Mayo Clinic, Minnesota, USA (2006-2009, 2010).

Research Collaborator in Oncology at that institution, and in 2011 she obtained the Mayo Clinic Certificate in Clinical and Translational Research.

Master’s degree in Oncology Services Management. University of Alcalá, Madrid (2013-2014).

Master’s degree in Research in Immuno-Oncology. University of Navarra, Pamplona (2015-2016).

Coordinator of the Breast Cancer Area at Clínica Universidad de Navarra from 2009 to 2014, and Co-Director from January 2015 to May 2022.

RESEARCH AREAS

  • Six-year research evaluation periods (sexenios) 2002-2010, 2011-2017, and 2018-2023.
  • Principal investigator of 5 funded research projects (one of them involving the use of dendritic cell vaccines in breast cancer) and co-investigator on 8 additional research projects.
  • Principal investigator in more than 15 clinical trials and sub-investigator in more than 20 clinical trials.
  • She has co-supervised 4 doctoral theses and served on the examination committee for 5 theses. She has supervised 12 undergraduate final projects (TFG) for students at the University of Navarra.
  • Member of the Research Ethics Committee for Medicines of Navarra, Department of Health, Government of Navarra (2018-2022)
  • Principal investigator of the IdisNA breast cancer group. Code 708A.

Reviewer for the following journals:

  • Biochemistry and Cell Biology. Nov2020
  • Clinical Cancer Research. Oct 2020.
  • Frontiers in Oncology. Sept 2020.
  • Journal of Chemotherapy. Ref.:  JOC1808R1. Dec 2019.
  • Pharmaceutical Research. Dec 2019.

AREAS OF INTEREST

  • Breast cancer
  • Cancer stem cells
  • Chemoresistance
  • Immunotherapy
  • Geriatric oncology

Activity

In teaching

  • Tenured Professor (accredited by ANECA).
  • Residency training tutor for the Medical Oncology specialty at Clínica Universidad de Navarra.
  • Course Director for the postgraduate subject “Clinical Challenges in Medical Oncology” at the School of Medicine since 2017.
  • Evaluator for continuing healthcare education accreditation, Department of Health, Government of Navarra.
  • She has supervised 12 undergraduate final projects (TFG).

In research

  • Author of 61 indexed publications, 1 book, and 7 book chapters.
  • She has presented more than 100 communications and lectures at national and international conferences.
Imagen de un icono azul con un documento certificado.

Scientific organizations

  • 2022-present Member of the Task Force of BIG (Breast International Group) in early development of new drugs.
  • 2020-present Member of the Evaluation Committee of the GEICAM Balil-Pelegrí grants.
  • 2000-present | Member of SEOM (Spanish Society of Medical Oncology).
  • 2012-present | Member of GEINO (Spanish Neuro-oncology Research Group).
  • 2012-present | Member of RTICC (thematic network of Cooperative Research in Cancer) in the call Networks 2012 (RD2012/0036/0063).
  • 2014-present | Member of the Commission for the Training of Medical Specialists, Colegio de Médicos de Navarra, Pamplona, Spain.
  • 2016-2018 | Member of the triple negative breast cancer group in GEICAM.
  • 2016-present | Coordinator of the UN breast cancer research group NEONCOBREAST.
  • 2017-current | Co-Principal Investigator of the biomarkers and cancer group at IdiSNA. Code 710C.
  • 2018-current | Member of the Ethics Committee of Research with drugs of Navarra. Department of Health. Government of Navarra.
  • 2018-current | Member of the Board of Directors of GEICAM.
  • 2020-current | Active member of the Translational Research group in GEICAM.
More information

Icono Scopus   SCOPUS

Icono RESEARCHID   RESEARCHID